SNDX Smart Money
Syndax Pharmaceuticals, Inc.
1W: +3.3%
1M: -23.4%
3M: -28.8%
YTD: -35.7%
1Y: +1.2%
3Y: +18.9%
5Y: -25.0%
$13.69
+0.47 (+3.56%)
Weekly Expected Move ±9.2%
$11
$12
$13
$15
$16
Credit Risk of going bust: higher than 66% of companies Debt: 32.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.61 (down 96%), Syndax Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $589.4M against a stock market value of $1.22B.
Distance to default 3.78 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $294.1M (short-term plus half of long-term), stock volatility 51.7%; Altman Z'' -3.36. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.61 (down 96%), Syndax Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $589.4M against a stock market value of $1.22B.
Distance to default 3.78 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $294.1M (short-term plus half of long-term), stock volatility 51.7%; Altman Z'' -3.36. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026283
Institutions Holding
+13 vs prior
194.5%
Ownership
+4.94%
40
New
94
Increased
115
Reduced
38
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | Metzger Michael A | officer: chief executive officer | S-Sale | 32,375 | $24.24 | $785K | Filing |
| 2026-06-12 | Botwood Nicholas A.J. | officer: head of r&d, cmo | S-Sale | 31,235 | $18.14 | $567K | Filing |
| 2026-06-11 | Botwood Nicholas A.J. | officer: head of r&d, cmo | S-Sale | 34,280 | $18.00 | $617K | Filing |
| 2026-06-01 | Goldan Keith A. | officer: chief financial officer | S-Sale | 1,177 | $18.99 | $22K | Filing |
| 2026-06-01 | Metzger Michael A | officer: chief executive officer | S-Sale | 6,847 | $18.99 | $130K | Filing |
| 2026-02-09 | Goldan Keith A. | officer: chief financial officer | S-Sale | 3,410 | $21.03 | $72K | Filing |
| 2026-02-09 | Metzger Michael A | officer: chief executive officer | S-Sale | 17,159 | $21.03 | $361K | Filing |
| 2026-02-06 | Metzger Michael A | officer: chief executive officer | S-Sale | 7,412 | $20.62 | $153K | Filing |
| 2026-02-06 | Goldan Keith A. | officer: chief financial officer | S-Sale | 2,082 | $20.62 | $43K | Filing |
| 2026-02-04 | Katkin Keith | director | A-Grant/Award | 24,000 | $— | $0 | Filing |
| 2026-02-04 | Huber Martin H. Jr. | director | A-Grant/Award | 24,000 | $— | $0 | Filing |
| 2026-02-04 | Jarrett Jennifer | director | A-Grant/Award | 24,000 | $— | $0 | Filing |
| 2026-02-04 | Legault Pierre | director | A-Grant/Award | 24,000 | $— | $0 | Filing |
| 2026-02-04 | Metzger Michael A | officer: chief executive officer | A-Grant/Award | 73,000 | $— | $0 | Filing |
| 2026-02-04 | Metzger Michael A | officer: chief executive officer | A-Grant/Award | 144,600 | $— | $0 | Filing |
| 2026-02-04 | Goldan Keith A. | officer: chief financial officer | A-Grant/Award | 30,750 | $— | $0 | Filing |
| 2026-02-04 | Goldan Keith A. | officer: chief financial officer | A-Grant/Award | 21,500 | $— | $0 | Filing |
| 2026-02-04 | Podlesak Dennis | director | A-Grant/Award | 48,000 | $— | $0 | Filing |
| 2026-02-04 | Rizo Aleksandra | director | A-Grant/Award | 24,000 | $— | $0 | Filing |
| 2026-02-04 | Botwood Nicholas A.J. | officer: head of r&d, cmo | A-Grant/Award | 36,000 | $— | $0 | Filing |
| 2026-02-04 | Botwood Nicholas A.J. | officer: head of r&d, cmo | A-Grant/Award | 24,000 | $— | $0 | Filing |
| 2026-01-30 | Goldan Keith A. | officer: chief financial officer | J-Other | 1,219 | $8.48 | $10K | Filing |
| 2025-12-01 | Goldan Keith A. | officer: chief financial officer | G-Gift | 1,224 | $— | $0 | Filing |
| 2025-09-08 | Metzger Michael A | officer: chief executive officer | S-Sale | 157,307 | $16.41 | $2.6M | Filing |
| 2025-08-18 | Podlesak Dennis | director | S-Sale | 19,200 | $15.84 | $304K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,020,006 | $197M | +765,580 | 2026-06-30 | Filing |
| Kynam Capital Management, LP | 8,050,959 | $176M | — | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 5,861,265 | $128M | +864,478 | 2026-06-30 | Filing |
| STATE STREET CORP | 5,658,424 | $124M | +1,228,348 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 4,045,094 | $88M | -204,742 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,927,892 | $86M | +105,313 | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3,779,900 | $83M | — | 2026-06-30 | Filing |
| Eversept Partners, LP | 2,798,210 | $61M | -87,412 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,584,136 | $56M | +427,078 | 2026-06-30 | Filing |
| Hood River Capital Management LLC | 2,564,279 | $56M | +209,994 | 2026-06-30 | Filing |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,500,000 | $55M | — | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 2,286,499 | $50M | +136,420 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 2,053,960 | $45M | +1,854,436 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,921,796 | $42M | +184,655 | 2026-06-30 | Filing |
| UBS Group AG | 1,893,750 | $41M | +740,088 | 2026-06-30 | Filing |
| Elmind Capital, LP | 1,855,000 | $41M | — | 2026-06-30 | Filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A | 1,790,173 | $39M | +57,632 | 2026-06-30 | Filing |
| Candriam S.C.A. | 1,696,040 | $37M | +770,708 | 2026-06-30 | Filing |
| Soleus Capital Management, L.P. | 1,628,039 | $36M | -98,869 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,578,125 | $34M | -1,471 | 2026-06-30 | Filing |